A phase 1 study of hepatic arterial infusion of oxaliplatin in combination with systemic 5-fluorouracil, leucovorin, and bevacizumab in patients with advanced solid tumors metastatic to the liver.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples